Here is the latest shareholding Pattern of SUN PHARMA. For more details, see the SUN PHARMA financial fact sheet and SUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Sep-24 |
3
Dec-24 |
3
Mar-25 |
3
Jun-25 |
3
Sep-25 |
3
Dec-25 |
3
Mar-26 |
3
Jun-26 |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Indian Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
| Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
| Mutual Funds | % | 12.11 | 12.24 | 12.21 | 12.63 | 12.41 | 12.09 | 11.96 | 12.84 | |
| Financial institution/Banks/Insurance | % | 5.00 | 4.79 | 4.95 | 5.15 | 6.04 | 6.66 | 6.93 | 7.07 | |
| Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FII | % | 18.01 | 18.05 | 17.96 | 17.26 | 16.55 | 16.12 | 15.93 | 14.54 | |
| Other | % | 1.50 | 1.51 | 1.54 | 1.71 | 1.78 | 2.06 | 2.22 | 2.25 | |
| Total Institution | % | 36.62 | 36.59 | 36.66 | 36.75 | 36.78 | 36.93 | 37.04 | 36.70 | |
| Bodies Corporate | % | 2.10 | 2.10 | 2.08 | 2.07 | 2.05 | 2.03 | 2.02 | 2.05 | |
| Individuals | % | 5.43 | 5.46 | 5.42 | 5.34 | 5.53 | 5.40 | 5.31 | 5.48 | |
| NRIs/OCBs | % | 0.29 | 0.28 | 0.29 | 0.28 | 0.29 | 0.28 | 0.28 | 0.29 | |
| ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Others | % | 1.08 | 1.09 | 1.08 | 1.08 | 0.86 | 0.87 | 0.87 | 1.00 | |
| Total Non-Institution | % | 8.90 | 8.93 | 8.87 | 8.77 | 8.73 | 8.58 | 8.48 | 8.82 | |
| Total Public | % | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
| Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Pledged Promoter Holding | % | 0.79 | 0.69 | 0.88 | 0.88 | 0.97 | 0.97 | 1.42 | 1.65 | |
More Pharmaceuticals Company Shareholding Pattern: CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES DIVIS LABORATORIES MANKIND PHARMA
Asian markets traded mixed on Tuesday.